Announcing Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Read UMR's Dec. 8 Letter to Congressional Leadership on the Urgent Need to Pass an FY23 Omnibus Appropriations Bill
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong
NIH's Role In Sustaining the U.S. Economy | 2022 Update Now Available

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

MilliporeSigma’s St. Louis workers are on front line of coronavirus fight

In the race to develop drugs and vaccines for COVID-19, MilliporeSigma rarely grabs any headlines, but it’s a critical supplier to companies that do. When you read about a lab working on a treatment for the coronavirus-caused disease, chances are good that it’s using reagents, or substances that cause chemical reactions, made by MilliporeSigma in St. Louis. Many vaccine scientists are using cell lines and culture media — the broth in which cells are grown — developed here in MilliporeSigma labs.